Praxis precision medicines to present at the american epilepsy society 2022 annual meeting

Boston, nov. 28, 2022 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will deliver presentations on its epilepsy programs at the american epilepsy society (aes) 2022 annual meeting, held december 2-6, 2022 in nashville, tennessee.
PRAX Ratings Summary
PRAX Quant Ranking